Lv3
360 积分 2023-05-06 加入
北京地区GPC3参考区间的建立及验证
22天前
已完结
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
25天前
已完结
Detection of Multiple HPV Types in Liquid Biopsies of Cervical Neoplasia
2个月前
已完结
Abstract 472: HER2 as a therapeutic target in bladder cancer
2个月前
已关闭
Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells
2个月前
已完结
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
2个月前
已完结
In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer
2个月前
已完结
Abstract 1359: Detection of PD-L1 positive circulating tumor cells from patient with bladder cancer
2个月前
已关闭
Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
2个月前
已完结
Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance
2个月前
已完结
皖公网安备34019202002308
